|50.62||-0.50 / -0.98%|
Data as of 4:01pm ET
|50.63||+0.01 / +0.02%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 56.00, with a high estimate of 63.00 and a low estimate of 34.00. The median estimate represents a +10.63% increase from the last price of 50.62.
The current consensus among 22 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.